Jones Day Welcomes Food & Drug Law Partner

WASHINGTON, Jan. 13 -- The global law firm Jones Day announced that Mark Mansour has joined the Washington Office as a partner in the Health Care and Life Sciences practices focusing on food and drug law. He was formerly a partner in Akin Gump Strauss Hauer & Feld LLP's Washington office. 

"Mark's arrival is another big step for our expanding food and drug law practice here in Washington," said Greg Shumaker, Partner-in-Charge of Jones Day's Washington Office. "Not only that, he bolsters our broader health care group, which is now second-to-none in town in helping clients deal with the seismic shifts wrought by the ACA and other policy changes. We're on a roll, with Colleen Heisey, also in food-and-drug; Alexis Gilroy in digital health; and Cathy Livingston, the IRS's top health care counsel, all joining us in just the last year." 

Mr. Mansour works with food, pharmaceutical, medical device, dietary supplement, and cosmetic industry clients to secure regulatory approvals, develop and maintain compliance strategies, and address public policy issues in the United States and other key global markets. Prior to entering private practice, he served as assistant general counsel and director of global regulatory affairs with two of the world's largest food companies, setting policies and global strategies on health and nutrition claims, fortification, packaging, food safety, FDA compliance, and removal of international regulatory and trade barriers.

"Mark brings to the table a powerful 360-degree perspective on food and drug issues, encompassing both global regulatory regimes and the strategic sensitivities of a corporate insider," said James Dutro, the San Francisco based co-chair of Jones Day's Health Care and Life Sciences practices. "I know that many of our clients around the world will be happy to have his counsel." 

A graduate of Georgetown University Law Center (J.D. 1988), Harvard University (M.A. 1983), and Georgetown University (B.S., cum laude, 1979), Mr. Mansour has written and spoken widely on food and drug law issues. Formerly a staff member of the U.S. House of Representatives, he has experience in a variety of international public policy matters, advising multinational companies and trade associations and working closely with congressional offices and U.S. government agencies on regulatory and trade issues affecting regulated industries. 

Jones Day is a global law firm with 40 offices in major centers of business and finance throughout the world. Its unique governance system fosters an unparalleled level of integration and contributes to its perennial ranking as among the best in the world in client service. Jones Day provides significant legal representation for almost half of the Fortune 500, Fortune Global 500, and FT Global 500.